- Home
- CMMB vs ATIP Comparison
CMMB vs ATIP Comparison
Compare CMMB & ATIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- ATIP
- Stock Information
- Founded
- CMMB 2004
- ATIP 1996
- Country
- CMMB Israel
- ATIP United States
- Employees
- CMMB N/A
- ATIP N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- ATIP Hospital/Nursing Management
- Sector
- CMMB Health Care
- ATIP Health Care
- Exchange
- CMMB Nasdaq
- ATIP Nasdaq
- Market Cap
- CMMB 27.0M
- ATIP 26.0M
- IPO Year
- CMMB N/A
- ATIP N/A
- Fundamental
- Price
- CMMB $1.64
- ATIP $2.21
- Analyst Decision
- CMMB Strong Buy
- ATIP
- Analyst Count
- CMMB 3
- ATIP 0
- Target Price
- CMMB $5.67
- ATIP N/A
- AVG Volume (30 Days)
- CMMB 99.6K
- ATIP 48.0K
- Earning Date
- CMMB 11-14-2024
- ATIP 11-04-2024
- Dividend Yield
- CMMB N/A
- ATIP N/A
- EPS Growth
- CMMB N/A
- ATIP N/A
- EPS
- CMMB N/A
- ATIP N/A
- Revenue
- CMMB N/A
- ATIP $728,114,000.00
- Revenue This Year
- CMMB N/A
- ATIP $10.99
- Revenue Next Year
- CMMB N/A
- ATIP $5.98
- P/E Ratio
- CMMB N/A
- ATIP N/A
- Revenue Growth
- CMMB N/A
- ATIP 9.29
- 52 Week Low
- CMMB $0.42
- ATIP $2.20
- 52 Week High
- CMMB $2.55
- ATIP $8.03
- Technical
- Relative Strength Index (RSI)
- CMMB 60.64
- ATIP 11.79
- Support Level
- CMMB $1.44
- ATIP $2.52
- Resistance Level
- CMMB $1.90
- ATIP $3.32
- Average True Range (ATR)
- CMMB 0.13
- ATIP 0.63
- MACD
- CMMB 0.04
- ATIP -0.34
- Stochastic Oscillator
- CMMB 67.49
- ATIP 5.20
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About ATIP ATI Physical Therapy Inc.
ATI Physical Therapy Inc is a recognized outpatient physical therapy provider in the United States specializing in outpatient rehabilitation and adjacent healthcare services. It offer a variety of services within the clinics, including physical therapy to treat spine, shoulder, knee and neck injuries or pain; work injury rehabilitation services, including work conditioning and work hardening; hand therapy; and other specialized treatment services.